US Congress · H.R. 5160 · Passed the House

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Introduced

Moved

Reached a final decision

Introduced 2025-09-04

Derived from the official record below.

Officially: “Stem Cell Therapeutic and Research Reauthorization Act of 2025” Read the full text

Health

What it does

Stem Cell Therapeutic and Research Reauthorization Act of 2025 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and prov

Summary by the Congressional Research Service, from the official record. Plain-language AI rewrite coming. Not legal advice.

Where it is

Introduced · 2025-09-04

In the House.

Passed the House · 2026-07-20

Senate floor vote · next · the next step

Official documents

Full bill textas published by GovInfo

official

Congressional Budget Office cost estimatewhat it would cost, by the nonpartisan CBO

official

The numbers

29%

of bills that passed one chamber became law in the 118th Congress, 2023 to 2024 (n=939)

sponsors, out of 218 needed to pass

Who is lobbying on this

ASTCTvia SMITHBUCKLIN CORPORATION

4 filings

NATIONAL MARROW DONOR PROGRAMvia NATIONAL MARROW DONOR PROGRAM

4 filings

NMDPvia VAN SCOYOC ASSOCIATES

4 filings

DUKE UNIVERSITY MEDICAL CENTERvia SIDLEY AUSTIN LLP

3 filings

AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOvia AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES

1 filing

NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATIONvia THE NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION

1 filing

From 17 filings in federal lobbying disclosures (LDA), via lda.gov, naming this bill (2025 to 2026). Filings are self-reported by lobbying firms and show who is paid to influence this bill. They do not say which side, or whether it worked.

Every fact on this page links to its source, starting with the official bill record. Last action: Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464. (2026-07-21).